Ongoing research
The following list shows an overview of ongoing research projects, using SHM's data. The list is filtered to show only those projects that are made available to the general public. For more information about the research projects, please read our latest annual report
| SHM no | Project title | Author(s) |
| I20109 | Update on trends in incidence and risk factors of anal cancer in HIV-infected patients | J. Prins, H. de Vries, P. Reiss, F. Wit, C. Smit, R.P. van der Zee |
| I20108 | Determining factors associated with disproportional weight gain in people with HIV with suppressed viremia switching antiretroviral therapy to an INSTI and/or TAF-containing regimen |
P. Reiss, M. Verburgh, F. Wit, S. Verboeket, A. Boyd, M. van der Valk |
| I20107 | HIV in Gelderland: characteristics of the infected population and testing behaviour among general practitioners | N. Nijsten, O. Richel, C. van Jaarsveld, G. ter Beest, K. Grintjes, A. van Sighem, R. van der Bij, S. Ostendorf, P. Dielissen, M. van de Luijtgaarden, R. Hermsen, C. van der Starre |
| I19105 | Remaining barriers to advancing hepatitis C micro-elimination in the HIV/HCV co-infected population in the Netherlands | M. van der Valk, C. Isfordink, J. Arends, C. Smit, A. Boyd |
| I19104 |
Long-term clinical and virological outcomes in aging perinatally and behaviourally HIV-infected young adults in the Netherlands (12-30 years) |
A. Weijsenfeld, C. Blokhuis, C. Smit, M. van der Valk, F. Wit, D. Pajkrt |
| I19100 | HIV treatment outcomes of transgender people versus the general HIV-positive population in the Netherlands | C. Daans, E. Hoornenborg, M. den Heijer, M. Prins |
| I17095 |
Evaluation of diagnosis, referral and treatment of acute HIV-1 infection at the Amsterdam STI clinic: trends over time |
De Bree G, Schim van der Loeff M, Dijkstra M, Prins M, Prins J, van Rooijen M, Hogewoning A, van Sighem AI. |
| I17093 |
The impact of mutations on the effectiveness of abacavir/lamivudine/dolutegravir regimens prescribed in treatment-experienced patients (The M184V/I – DTG study) |
Olearo F, Kouyos R, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Baettig V, Cavassini M, Gayet-Ageron A, Scherrer A, Schmid P, Bucher HC, Günthard H, Böni J, DÁrmino A, Zazzi M, Bellecave P, Cazanave C, Daffau P, Rijnders B, Reiss P, Wit F, Calmy A. |
| I17092 |
Impact of the Positive Sisters peer support program on health outcomes in HIV-positive migrant women in the Netherlands |
F. Cobelens, L. Darvey, M. Adhikari, S. Boender |
| I16091 |
Longitudinal virological outcomes and factors associated with virological failure in HIV infected young adults in the Netherlands 1996-2016 |
Weijsenfeld AM, Wit FWNM, Pajkrt D. |
| I16072 |
Comparison of the occurrence of HBV-related liver disease and (liver-related) mortality between patients with hepatitis B mono-infection and patients coinfected with hepatitis B and HIV in the Netherlands |
Arends JE, Richter C, Lieveld FI, Reiss P, Smit C, Spanier M, van Erpecum KJ, Hoepelman IM. |
| I16060 |
Evaluation of dolutegravir use of the treatment of HIV in the Netherlands: focus on switchers and adverse events |
D. Burger, R. van Crevel, A. Brouwer, P. Bollen, J.E. Arends, C.S. Hakkers, I.M. Hoepelman, K. Brinkman, G.E.L. van den Berk, F. Wit |
| I16038 |
Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients |
van Bilsen WPH, van den Berg CHSB, Rijnders BJA, Brinkman K, Mulder JW, Gelinck LBS, Hoepelman AIM, Wit FWNM, van de Beek D, Prins JM. |
| I16011 |
Type of cART regimen and the risk for immune reconstitution and inflammatory syndrome in HIV-1 infected patients. Is integrase inhibitor use an independent risk factor? |
Wijting IEA, Wit FWNM, Rokx C, Leyten EMS, Lowe SH, Brinkman K, Bierman WFW, van Kasteren MEE, Postma AM, Bloemen VCM, Bouchtoubi G, Hoepelman AIM, van der Ende ME, Reiss P, Rijnders BJA. |
| I15148 |
Model based on clinical parameters to predict the natural history of severe liver fibrosis in HIV/HCV coinfected patients |
J. Arends, A. van der Meer, C. Smit, B Hansen |
| I15090 |
Fibrosis progression after acute HCV infection in HIV-infected individuals |
M. van de Valk, K.W. Kooij, A. Newsum, C. Smit, P. reiss, M. Prins, J. van der Meer, MOSAIC Study Group, SHM Werkgroep Hepatitis |
| I15066 |
Cost-effectiveness of HIV treatment and care in the Netherlands |
A. Verbon, B.E. Nichols, C. Boucher, S. Geerlings, P. Reiss, A. van Sighem, F.P. Kroon, M.J. Postma, K. Brinkman |
| I15065 | Comparison of the occurrence of severe HBV-related liver disease and (liver-related) mortality between patients with hepatitis B mono-infection and patients coinfected with hepatitis B and HIV in the Netherlands. (HARMONIC) | J.E. Arends, C. Richter, F.I. Lieveld, P. Reiss, C. Smit, M. Spanier, K.J. van Erpecum, I.M. Hoepelman |
| I15043 | Cost-Effectiveness of the Adherence Improving self-Management Strategy (AIMS) in HIV-care: A model-based economic evaluation | M. de Bruin, J. Prins, E. Oberjé, M. Hiligsmann, S. Evers, L. Gras |
| I15021 |
Global resistance following virologic failure with tenofovir +NNRTI containing antiretroviral regimens: a retrospective multi-centre multi-cohort study and meta-analyse |
C. Rokx, R. Gupta, B. Rijnders, B. Shafer, J. Gregson, M. Tang, R. Hamers, E. Raizes, K. Crawford, V. Marconi, A. Hill, M. Hosseinipour, N. Clumeck, P. Kanki, S. Lockman, T. Rinke de Wit, S. Hoffman, T. de Oliveira, C. Wallis, L. Morris, G. Hunt, D. Dunn, J.L. Blanco, H. Gunthard, Dr. Kumarasamy, P. Kaleebu, D. Pillay, C. Charpentier, D. Descamps, A. van Damme, K. Theys, R. Camacho, V. Calvez, L. Gras |
| I15004 | The impact of combinations of strategies for HIV prevention among men who have sex with men | M. Xiridu, A. van den Bosch, B. van Benthem, E. Op de Coul, A. van Sighem, I. Stolte |
| I14201 | Failure of donor selection: what can the virus of the donor tell us? | T. van de Laar, D. Bezemer, H. Zaaijer, P. van Switten, A. van Sighem, E. Vlaas, V. Compernolle, G. Vanderwalle, A. de Smet, K. van Laethem, A. Vandamme |
| I14145 | Evaluation of an evidence-based, Internet-supported self-help program for people living with HIV suffering from mild to moderate depressive symptoms | N. Garnefski, V. Kraaij, S. van Luenen |
| I14087 | Clinical experience with rilpivirine (KLII study) | E. Roelofsen, D.M. Burger, D.J. Touw, L.B.S. Gelinck, E.B. Wilms |
| I14067 | Predictive value of cardiovascular risk equations in the HIV-infected population receiving care in the Dutch HIV treatment centers | F. Wit, R. van Zoest, I. Vaartjes. L. Gras, J. Arends, P. Reiss |
| I14065 | Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients: Implications for screening strategies | G. Wandeler, A. Rauch, P. Reiss, C. Smit, M. van der Valk, J. Arends |
| I13120 | SPREAD Program 3.0 - Surveillance of transmission of HIV- drug resistace | A.M.J. Wensing, C.A.B. Boucher, K. Brinkman, J. van der Meer, I. van de Ende, C. Richter, E. Schippers, D. de Vries-Sluijs, J. Schinkel, C. Smit |
| I13061 | Factors associated with time to HIV RNA suppression in women with HIV infection starting antiretroviral treatment during pregnancy | T. Mudrikova, W. van Snippenburg, A. Wensing, J. Nellen, M. Godfried, C. Smit |
| I13059 | Clinical, Immunological, Virological and Social outcomes of cART treated HIV infected children after transition into adult health care services. (CLIVIA study) | A.M. Weijsenfeld, M. Mutschelknauss, F.J.B. Nellen, C. Smit, D. Pajkrt, L. van der Knaap, H. de Jonge, N. Nauta, R.Strik-Albers |
| I13051 | Barrières voor hiv preventie, testen en zorg onder migranten (aMASE) | M. Prins, F. Zuure, J. Bil, F. Burns, J. del Amo |
| I13032 | Combined and Comparative Analysis of Virulence Trends Across Multiple Cohorts | L. Gras, F. de Wolf, J. Herbeck, V. Mueller |
| I12045 | A HIV-1 genome wide association study to identify viral determinants of HIV-1 plasma concentration (BEEHIVE) | F. de Wolf, B. Berkhout, M. Cornelissen, C. Fraser, P. Kellam, A. Gall, L. Gras, A. van Sighem |
| I10021 | Characteristics of HIV-1 transmission among men having sex with men in the Netherlands | O. Ratmann |
| I08115 | Proposal for collaboration and data exchange between HMF and RIVM for nation HIV/AIDS surveillance and data transfer to ECDC in the context of EU obligations for reporting on HIV/AIDS | E. op den Coul, F. de Wolf, M. van der Sande, A. van Sighem, J. Vlug |
| I05513 | HIV Resistance Response Database Initiative (RDI) | A. Revell |
| I04034 | The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) | P. Reiss |